SHC sunshine heart, inc.
Add to My Watchlist 0.00% ! 2.5¢

https://www.pharmamedtechbi.com/publications/the-gray-sheet/40/26...

  1. tootip
    1,224 Posts.
    clock Created with Sketch.
    11/10/14
    10:53
    Post #: 14110209
    https://www.pharmamedtechbi.com/pub...nrollment-for-emcpulse-emheart-failure-device

    Sunshine Heart Endures Slow Enrollment For C-Pulse Heart Failure Device

    By Reed Miller / Email the Author / View Full Issue
    Top Stories / Word Count: 1411 / Article # 01140630003 / Posted: June 24 2014 6:00 PM
    Executive Summary


    Sunshine Heart CEO David Rosa details the challenges of enrolling patients in a trial targeted specifically at patients with Class III heart failure. The firm hopes the study of the C-Pulse heart assist system can be completed by early 2016, but is also cooking up a plan to start submitting data to FDA before enrollment finishes.
    SHC Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.